Target intelligence / Profile preview

Cell division control protein 42 homolog (Cdc42) – Intersectin-1 (ITSN1) binding interface (Cdc42-ITSN1 interface)

Target
Cdc42-ITSN1 interface
Molecular classification
Small GTPase, Guanine nucleotide exchange factor, Protein-protein interaction interface
01

Overview

The Cell division control protein 42 homolog (Cdc42) – Intersectin-1 (ITSN1) binding interface is a pivotal regulatory junction in the Rho GTPase signaling pathway. Cdc42 acts as a molecular switch, alternating between an inactive GDP-bound form and an active GTP-bound form to regulate the actin cytoskeleton, cell polarity, and membrane trafficking (UniProt P60953). Intersectin-1 (ITSN1) serves as a Guanine Nucleotide Exchange Factor (GEF) that catalyzes this activation by interacting with the Switch I and Switch II regions of Cdc42 via its Dbl homology (DH) domain (Friesland et al., 2013). This specific interface is a therapeutic target because its hyperactivation is associated with cancer cell invasion, metastasis, and certain neurodegenerative disorders like Alzheimer's disease (Aguilar et al., 2017). Small molecules like ZCL278 have been developed to bind this interface, effectively preventing ITSN1 from activating Cdc42 and thereby inhibiting downstream oncogenic processes (Friesland et al., 2013). Targeting this protein-protein interaction provides a more selective approach than broad GTPase inhibition, potentially reducing off-target effects in clinical applications.

Other names
Cdc42-ITSN interfaceCdc42-Intersectin-1 interaction siteCdc42 Switch I-ITSN1 DH domain interfaceCdc42-ITSN1 complex
02

Mechanism of action

Small molecule inhibition of the interaction between Cdc42 and its guanine nucleotide exchange factor (GEF) Intersectin-1, preventing the exchange of GDP for GTP and thus maintaining Cdc42 in an inactive state (Friesland et al., 2013).

03

Biological functions

Signal transductionActin cytoskeleton organizationCell migrationCell polarityEndocytosis
04

Disease associations

CancerMetastasisNeurodegenerative diseaseDevelopmental disorder
05

Safety considerations

Off-target effects on other Rho GTPases (e.g., Rac1, RhoA)Disruption of essential cell motility and polarity in healthy tissuesPotential impact on immune cell trafficking and wound healing
06

Interacting drugs

ZCL278
07

Biomarkers

Cdc42-GTP levelsITSN1 expressionActin polymerization rate

Beyond the preview

Go deeper on Cell division control protein 42 homolog (Cdc42) – Intersectin-1 (ITSN1) binding interface (Cdc42-ITSN1 interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell division control protein 42 homolog (Cdc42) – Intersectin-1 (ITSN1) binding interface (Cdc42-ITSN1 interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call